Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Pfizer
Scientific Title
A Multicenter, Open-label, Phase 1b/2 Study To Evaluate Safety And Efficacy Of Avelumab (msb0010718c) In Combination With Chemotherapy With Or Without Other Anti-cancer Immunotherapies As First-line Treatment In Patients With Advanced Malignancies